Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing small molecule therapeutics to treat specific diseases. Their focus is on advancing targeted therapies that address unmet medical needs in oncology and other therapeutic areas.

BIOMx develops customized bacteriophage therapies to target and eliminate harmful bacteria associated with chronic diseases such as cystic fibrosis and diabetic foot osteomyelitis. By validating proprietary bacterial targets, the company creates tailored phage compositions that enhance treatment efficacy and patient outcomes.

Biond Biologics develops biological therapies targeting immune evasion mechanisms in cancer patients, utilizing their proprietary INspire intracellular delivery platform for biologics. This approach enhances the efficacy of treatments by improving the delivery and effectiveness of therapeutic agents within cancer cells.

Bionsight combines chemoproteomics with artificial intelligence to accelerate therapeutic target identification and validation. The platform decodes complex protein-ligand interactions to reveal novel mechanisms of action with high precision. This approach enables pharmaceutical companies to predict efficacy, profile safety, and optimize lead compounds faster in the drug discovery pipeline.

Chemomab Therapeutics is a clinical-stage biotech company developing CM-101, a humanized monoclonal antibody that neutralizes the soluble protein CCL24, which drives inflammation and fibrosis in diseases such as primary sclerosing cholangitis and liver fibrosis. The company targets fibro-inflammatory-related diseases with high unmet medical needs, aiming to improve patient outcomes by interrupting the pathological processes that lead to excessive tissue scarring.

Cylus provides CylusOne, a cybersecurity solution that utilizes deep packet inspection and real-time monitoring to protect railway operational technology from cyber threats. The platform ensures continuous asset visibility and threat detection across all rail systems, enhancing safety and operational integrity in the railway industry.

Dice is a corporate spend orchestration platform that integrates procurement, accounts payable, and expense management to streamline financial operations for enterprises. By connecting over 500,000 employees and 150,000 vendors, Dice enhances transaction efficiency and compliance, processing $1.5 billion annually while reducing reconciliation time by 0%.

E INC enhances the automotive purchasing process by providing a digital platform that streamlines wholesale and retail transactions through advanced technology and data analytics. This approach addresses inefficiencies in the automotive ecosystem, enabling faster and more flexible business operations for dealers and consumers.

LanceDB is an open-source database designed for multimodal AI applications, enabling rapid vector search and advanced data retrieval from large-scale datasets. It addresses the challenges of managing and scaling AI data by providing a performant solution that integrates seamlessly with existing data pipelines and supports real-time analytics.

ImmunoBrain Checkpoint is a biopharmaceutical company focused on developing immune checkpoint inhibitors to enhance the bodys immune response against brain tumors. Their technology aims to improve treatment outcomes for patients with glioblastoma by targeting specific pathways that tumors exploit to evade immune detection.

Provides a shared progress tracking platform for coaches and clients, enabling clients to log actions, track goals, and maintain accountability between sessions. Coaches gain measurable insights into client progress and engagement through customizable logs, reminders, and real-time feedback tools, improving the effectiveness of their practice.

Lo provides a platform for managing and automating commercial real estate leasing workflows. It centralizes lease documentation, tracks key dates, and streamlines communication between landlords and tenants. This system helps commercial property managers reduce administrative overhead and ensure compliance across their portfolio.

O is developing an IoT device that visualizes the human circadian clock to enhance individual and organizational performance through data-driven insights. The platform provides actionable recommendations based on sleep data, addressing productivity issues and mental health risks within teams.

OASIS develops a real-time photorealistic video communication platform using generative AI and a patented peer-to-peer VR chat protocol that consumes 100x less bandwidth than traditional services like Zoom. Their technology enables the rendering of lifelike AI avatars on consumer devices with 10,000x less computational power than existing generative models, facilitating effortless human communication.

Provides a corporate gifting platform that integrates with existing tech stacks to automate and manage global gift campaigns. It helps businesses strengthen customer and employee relationships, track ROI through detailed analytics, and reduce logistical challenges with end-to-end gift fulfillment and budget management tools.

Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.

The startup develops a medical device that enhances infant stability and comfort during spinal tap procedures by maintaining an upright position for optimal access to the spinal fluid column. Utilizing ultrasound data, the device significantly increases interspinous space, facilitating more effective treatment by healthcare professionals.

Trigo offers a vision‑AI platform that turns existing in‑store camera feeds into real‑time loss‑prevention alerts, autonomous checkout, and detailed shopper behavior analytics. Using proprietary non‑biometric computer‑vision algorithms, the system processes millions of shopping events while preserving privacy and delivers insights through cloud dashboards and API integrations for large retailers.